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which are G-protein coupled seven-transmembrane proteins (Buck and Axel, 1991) .
In the mouse, there are 1,099 OR genes with an intact open reading frame, of which 1,087 are expressed at the RNA level in OSNs (Saraiva et al., 2015) .
Due to the difficulty in raising antibodies against G-protein coupled receptors, there have been relatively few reports about OR proteins in the literature. Initial studies with antibodies against rat ORs suggested that the antigen is localized to the cilia of OSNs in the rat MOE (Koshimoto et al., 1992; Krieger et al., 1994) . In situ hybridization against OR RNAs in mouse revealed that OR gene expression is restricted to OSNs within discrete regions of the MOE called zones (Ressler et al., 1993; Miyamichi et al., 2005) . Gene-targeted mice enabled the visualization of entire
OSNs expressing a given OR by targeted integration of a cassette that affords cotranslation of the OR with a marker such as taulacZ via an internal ribosome entry site (IRES) (Mombaerts et al., 1996) . Axons of OSNs expressing the same OR coalesce into two or a few glomeruli per mouse olfactory bulb, which reside in highly restricted regions (Ressler et al., 1994; Mombaerts et al., 1996; Zapiec and Mombaerts, 2015) . Replacement of the OR coding region showed that the OR does not only mediate odorant detection (Bozza et al., 2002) , but is also a determinant of where in the olfactory bulb the axons coalesce and form glomeruli (Mombaerts et al., 1996; Feinstein et al., 2004; Feinstein and Mombaerts, 2004 (Feinstein et al., 2004) .
Antibodies against mouse ORs revealed that OR proteins are present not only 6 in OSN cilia, dendrite, and cell body but also within the axon and axon terminals (Barnea et al., 2004; Strotmann et al., 2004) , thus supporting the notion that the OR protein is involved in axonal wiring of OSNs.
A quarter of a century after the discovery of mammalian OR genes (Buck and Axel, 1991) , there are still few papers on immunfluorescence staining of the mouse MOE and olfactory bulb with OR antibodies that are commercially available. There are numerous antibodies against ORs on the market, but they remain largely uncharacterized. The signal yielded by such antibodies can be affected by the high sequence homology between ORs, by post-translational modifications, by protein folding, by protein-protein interactions, and by fixation crosslinking. To increase the accessibility of the antigen to the antibody, antigen retrieval can be used to break some of the crosslinks formed during fixation and to alter the protein re-folding following heat denaturation (Shi et al., 2001; Emoto, 2005 Mice were anesthetized by injection of ketamine HCl and xylazine (120 mg/kg and 5 mg/kg body weight, respectively) and perfused with 5 ml ice-cold phosphate buffered saline (PBS), followed by 15 ml 2% paraformaldehyde in PBS (PFA). The mouse heads were dissected, postfixed in 2% PFA for 2 hr at 4°C, and decalcified in 0.45 M EDTA in PBS overnight at 4°C. Samples were cryoprotected in, successively, 15% and 30% sucrose in PBS at 4°C, frozen in O.C.T. Compound (Tissue-Tek), sectioned at 12 µm with a Leica CM3500 cryostat, and collected onto glass slides.
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Alternative fixation methods were also tested; perfusion with 4% PFA resulted in poorer antigenicity, and immersion fixation in 2% PFA for 2 hr without perfusion did not yield improved antigenicity.
Antigen retrieval
Various antigen retrieval steps were tested to optimize visualization of the target protein. These included a 10-min incubation in 2 M HCl at room temperature, or 10 min ice-cold 100% methanol followed by 0.5% sodium dodecyl sulfate (SDS) in PBS at room temperature. Antigen retrieval with a pressure cooker (2100 Retriever;
BioVendor) was carried out with 10 mM citric acid pH 6.0 and 10 mM Tris pH 9.0 with or without 0.05% Tween 20 and 2 mM EDTA. After heating in a pressure cooker to 121˚C, slides were left to cool for 2 hr in the retrieval buffer. Additionally, PBS washes were tested with 0.05% Tween 20 or 0.2% Triton X-100, and incubation with antibody was tested for various times during a period of 1-4 days, with and without 0.1% Triton X-100. Best results were obtained with PBS washes and incubation with antibody diluted with 0.1% Triton X-100. There was no obvious difference in antigen detection with different incubation times.
Immunohistochemistry
Slides were washed 3 x 10 min with PBS, and, if necessary, antigen retrieval was carried out and the slides were again washed. Slides were then blocked with 10% normal goat serum (Jackson ImmunoResearch Laboratories) or normal donkey serum (Millipore) in PBS for 1 hr at room temperature. After blocking, slides were incubated with the primary antibodies in 1% normal goat serum or normal donkey serum with 0.1% Triton X-100 in PBS overnight at 4°C. Mice were anesthetized by injection of ketamine HCl and xylazine (120 mg/kg and 5 mg/kg body weight, respectively) and perfused with 15 ml ice-cold 4% PFA.
The mouse heads were dissected, postfixed in 4% PFA, and decalcified in 0.45 M EDTA in PBS overnight at 4°C. Samples were cryoprotected in 15% and 30% sucrose in PBS at 4°C, frozen in O.C.T. Compound (Tissue-Tek), sectioned at 12 µm with a Leica CM3500 cryostat, and collected onto glass slides.
In situ hybridization and immunohistochemistry OR RNAs were detected with biotinylated riboprobes against Olfr156 (Strotmann et al., 1999) ; Olfr412 (forward 5'-ATGGACGGAGGCAACCAGA-3', reverse 5'-GGCTTCCTTAGCAGTCTTCCC-3'), and Olfr552 (Addgene plasmid #15843; Hirota et al., 2007) . Riboprobes were generated as described in Ishii et al. (2004) . Combined immunohistochemistry and in situ hybridization was carried out using a modified protocol from Ishii et al. (2004) . Briefly, slides were washed with PBS and antigen retrieval was carried out with 10 mM citric acid pH 6.0. 
RESULTS RESULTS RESULTS
We screened 40 commercially available antibodies that were raised against human or mouse ORs in the mouse MOE, testing various antigen retrieval methods to optimize visualization of the antigen. Of these 40 antibodies, 19 were raised against human
ORs with ~80% amino acid identity to mouse ORs, and 21 were against mouse ORs.
Here we present the results from 9 of the antibodies that yielded reproducible immunostaining in the mouse MOE ( (Fig. 1A@B' ) and the OR1L8 antibody (Fig. 1C@D' ) co-labeled with the OMP antibody, suggesting that they crossreact with one or more mouse OR proteins in the MOE. The mouse ORs with the closest homology to these human ORs are Olfr412 (81% identity with OR1D4 across the entire amino acid sequence of the OR) and Olfr355 (78% identity with OR1L8 in the amino acid region 200-250 from which the antigenic peptide was designed). For the OR1D4 and OR1L8 antibodies, immunoreactivity was observed midway along the dorsal-medial and ventral-lateral aspect of the MOE. OR51E1 imunoreactivity was observed more ventral-laterally. The rabbit OR51E1 antibody reacted with an antigen in the mouse MOE (OR51E1 has 87% identity with mouse Olfr558 in the amino acid region 270-317 from which the antigenic peptide was designed): signal was detected in cell bodies, but there was no evidence of immunoreactivity in cilia or dendrites.
Furthermore OR51E1 immunoreactivity did not colocalize with OMP immunoreactivity (Fig. 1E@F') . The Olfr2 and Olfr6 antibody labeling was observed in the ventral-lateral aspect of the MOE, and appeared weak (Fig. 2) . Olfr2 labeling was best observed after antigen retrieval in the pressure cooker with citric acid, and Olfr6 labeling was observed with both citric acid and Tris antigen retrieval buffers in the pressure cooker. Low signal could be due to low protein expression of the Olfr2 and Olfr6
ORs, low sensitivity of the antibodies, or suboptimal fixation and antigen retrieval procedures. Fortunately, there are gene-targeted mouse strains available for these two ORs, respectively mI7-IRES-tauGFP (Bozza et al., 2002) and M50-IRES-GFP-IRES-taulacZ (Feinstein et al., 2004) . These strains enabled us to validate that Olfr2
( Fig. 2A@B') and Olfr6 (Fig. 2D@E') antibody labeling was limited to cells that were also GFP-positive, indicating that the antibody is specific to the respective OR.
Neither antibody against Olfr2 (Fig. 2C@C') or Olfr6 (Fig. 2D@D' ) detected protein expression in the GFP-positive glomeruli in the olfactory bulb.
The Olfr156 antibody yielded signal midway along the dorsal-medial and ventral-lateral aspect of the MOE, and appeared to have low immunoreactivity (Fig.   3A@B' ). SDS/methanol antigen retrieval sporadically reveled positive labeling, and citric acid antigen retrieval yielded more reproducible signal. In both cases only cilia were labeled consistently, and the cell body, and dots within the dendrites, were visible on rare occasions. It is possible that the antigen is more accessible in certain subcellular localizations; there may be modifications occurring to the OR protein that allow detection under certain conditions; or an increased density of OR protein in certain subcellular localizations, such as in the cilia, may make it more easy to visualize.
The Olfr412 antibody showed strong immunoreactivity following citric acid antigen retrieval, and signal was detected in the dorsal-medial aspect of the mouse MOE (Fig. 3C@D') . This pattern differs from the OR1D4 antibody, which yielded signal midway along the dorsal-medial and ventral-lateral aspect of the MOE. Thus, although Olfr412 is the mouse OR with the highest homology (80%) to human OR1D4, it is unlikely to be the antigen that the OR1D4 antibody detects.
14 The Olfr552 antibody also showed strong immunoreactivity in the mouse MOE ( Fig. 3E-F' ). This antibody did not require antigen retrieval, but the signal was greatly improved following antigen retrieval with citric acid. Signal was detected through the dorsal-medial aspect of the mouse MOE. Two glomeruli were detected in the olfactory bulb. Consistent with Olfr552 belonging to class I ORs, the labeled glomeruli resided within the class I dorsal domain of the olfactory bulb. The medial glomerulus was located midway along the anterior-posterior extent, and the lateral glomerulus ( Fig. 3G) was located more anteriorly.
For Olfr156, Olfr412, and Olfr552, there are no gene-targeted mice available to validate that the antibody is specific for the respective OR. Instead we used in situ hybridization combined with immunohistochemisty to verify that these antibodies were labeling the intended OR. Combining these methods compromises the quality of both techniques, and we were unable to detect antibody labeling with Olfr156 in combination with in situ hybridization. We were able to detect both protein and RNA in the mouse MOE for Olfr412 (Fig. 4A@B') and Olfr552 (Fig. 4C@D') . We could thus verify that Olfr412 and Olfr552 antibody labeling was closely associated with the signal from respective riboprobes in the mouse MOE, indicating the antibodies are labeling the cells that express the respective OR gene. The sensitivity and specificity of these antibodies could not be verified using this method of combined labeling.
Finally, the Olfr1507 antibody showed strong immunoreactivity in the ventrallateral aspect of the mouse MOE (Fig. 5) , and did not require antigen retrieval to be visualized. Signal could be detected in the cilia, dendrite, and cell body of OSNs.
Immunostaining colocalized with GFP expression in mice homozygous for the MOR28-IRES-gap-GFP gene-targeted mutation (Serizawa et al., 2000) (Fig. 5A@B') .
We also detected strong immunoreactivity in GFP-positive glomeruli in the olfactory bulb (Fig. 5C@C') . Having a reliable antibody that detects a mouse OR for which we have a gene-targeted mouse strain available gave us the opportunity to investigate monoallelic expression of Olfr1507 in mice heterozygous for MOR28-IRES-gap-GFP, with the other, wild-type MOR28/Olfr1507 allele either of C57BL/6J origin (abbreviated B6) or 129S6/SvEvTac origin (abbreviated 129) (Fig. 5D@E') . The MOR28/Olfr1507 gene targeting had been carried out in an embryonic stem cell line 15 of 129 origin (Serizawa et al., 2000) . We observed an even distribution of cells that are doubly GFP-positive and antibody-positive throughout the MOE, versus cells that are antibody-only positive. In the olfactory bulb we found that the GFP-positive glomeruli were labeled with the Olfr1507 antibody in MOR28-IRES-gap-GFP +/-mice (Fig. 5F@F') . The glomeruli did not appear to be homogeneously labeled with
Olfr1507 and GFP antibodies in MOR28-IRES-gap-GFP +/-mice. Instead, there is a segregation of axon terminals expressing the gene-targeted and wild-type Olfr1507
alleles. This segregation was observed in MOR28-IRES-gap-GFP +/- (129) 
in total: MOR28-IRES-gap-GFP -/-(n = 5), MOR28-IRESgap-GFP +/-(B6) (n = 4), MOR28-IRES-gap-GFP +/-(129) (n = 3), wild-type
C57BL/6J (n = 5), and wild-type 129S6/SvEvTac (n = 3) mice. To correct for overcounting in sections, we performed an Abercrombie correction (Abercrombie, 1946; Bressel et al., 2016) (Table 2) . We observed no significant difference in the nuclear diameter between strains, and used a correction factor of 0.68-0.69.
In all five types of mice, we observed a distinct 'M'-pattern distribution of Olfr1507-immunoreactive OSNs in the MOE, with the peaks corresponding to the ectoturbinates of the MOE (Fig. 6A) . The first Olfr1507-immunoreactive cells were observed midway along the anterior-posterior dimension, between 3.5@4 mm from the start of the MOE. The expression peaked after approximately 1 mm, then began to drop off, but expression quickly increased again, and continued to the most posterior portion of the MOE.
In MOR28-IRES-gap-GFP -/-mice, we found that 0.94 ± 0.4% of the counted cells were labeled with only the Olfr1507 antibody but not with the GFP antibody, suggesting that the antibody is highly specific for Olfr1507-expressing cells in the mouse MOE. Conversely, in these mice only 0.40 ± 0.2% of the counted cells were labeled with the GFP antibody but not with the Olfr1507 antibody, indicating that the antibody is also highly sensitive. Therefore, we conclude that the antibody against an 16 Olfr1507 peptide that is commercially available from Osenses (OSR00212W) is a reliable, specific, and sensitive detector of Olfr1507-expressing OSNs in the mouse MOE, with 98.66 ± 0.4% of counted cells labeled with both the Olfr1507 antibody and the GFP antibody in MOR28-IRES-gap-GFP -/-mice (Fig. 6B) .
Next, we examined the two populations of Olfr1507-expressing OSNs for each allele in MOR28-IRES-gap-GFP +/-mice. OSNs that labeled with both the Olfr1507 and GFP antibodies were considered to express the MOR28-IRES-gap-GFP genetargeted allele, and OSNs that labeled with only the Olfr1507 antibody were considered to express the wild-type allele. In both MOR28-IRES-gap-GFP +/- (B6) and MOR28-IRES-gap-GFP +/-(129) mice, we observed a homogeneous distribution of the two populations throughout the MOE ( distribution than when the wild-type allele is of B6 origin. Note that expression of the gap-GFP reporter is driven by a 129-derived promoter sequence in the genetargeted mutation (Serizawa et al., 2000) .
Further support for the idea that the probability of expression of Olfr1507 is higher for the B6 allele than for the 129 allele, came from comparing the numbers of immunoreactive cells in the various strains. In MOR28-IRES-gap-GFP -/-mice we counted 31,657 ± 2,305 Olfr1507-immunoreactive cells, and these numbers were not statistically different from MOR28-IRES-gap-GFP +/-(129) mice (36,897 ± 1,547), or 129S6/SvEvTac wild-type mice (24,985 ± 1,448) (Fig. 6C) . Likewise, the numbers of cells counted in MOR28-IRES-gap-GFP +/-(B6) mice (41,988 ± 3,142) and in C57BL/6 wild-type mice (43,500 ± 3,606) were not significantly different from each other, but were significantly higher than in MOR28-IRES-gap-GFP -/-mice and in 17 129S6/SvEvTac wild-type mice (one-way ANOVA P < 0.003; Fig. 6C ). Incidentally, we did not identify a significant correlation between the number of Olfr1507-immunoreactive OSNs counted in the MOE and the weight of the mice, indicating that the differences in cell numbers were not due to trivial variations in mouse weight (Fig. 6D) We have demonstrated that a substantial fraction (at least 20%) of commercially available antibodies are a viable way for assessing OR expression in the mouse MOE.
We found that tissue fixation had an effect on the quality of antigen detection, with perfusion with 2% PFA being optimal. For the antibodies that we were unable to get to work, other fixation methods may yield better and consistent signals. We also tested various antigen retrieval methods, and found that when antigen retrieval was required, the best results were often obtained with antigen retrieval in a pressure cooker with a citric acid buffer, pH 6.0. While alternative antigen retrieval methods also worked, we found that if signal could still not be detected after antigen retrieval with citric acid, alternative methods would also be without success. Some antibodies yielded strong signals, and for others the signal was barely or inconsistently detectable. It would be interesting to determine if the variation in signal is a result of variable antigenicity of the antibodies, or reflects widely differening levels of protein expression within OSNs expressing these particular ORs.
We confirm and extend the observations of OR immunoreactivity in the cell body and dendrite as well as in the cilia of OSNs (Barnea et al., 2004; Strotmann et al., 2004) . In the dendrite, and sometimes in the cell body of OSNs, a distinct dot-like pattern could be detected. This pattern of signal could be an artifact of antibody staining. Nevertheless, it is a repeatable observation with various antibodies against ORs, and we reported it earlier in the M71::GFP fusion mouse strain (Feinstein et al., 2004) , suggesting that this dot-like pattern of OR protein signal reflects a biological process. It could be related to the visualization of specific forms of protein folding, it may be due to increased density of protein as a result of pulsed transcription, or it may be related to protein trafficking. This issue can be examined further through the use of antibodies against ORs in combination with membrane markers, and with 19 super-resolution microscopy. 
Glomerular labeling Glomerular labeling Glomerular labeling Glomerular labeling
In most cases we were unable to detect a reliable signal in glomeruli. But with 3,600 glomeruli in the mouse olfactory bulb (Richard et al., 2010) , it remains possible that we overlooked the glomerular signal for some antibodies. For two antibodies (Olfr552 and Olfr1507/MOR28) we were able to visualize specific glomeruli.
Interestingly, both of these antibodies did not require antigen retrieval to be detected. Even when antigen retrieval was performed, the glomeruli were still detected, suggesting that antigen retrieval itself was not inhibiting the detection of glomeruli with the other antibodies.
In both MOR28-IRES-gap-GFP +/-(B6) and MOR28-IRES-gap-GFP +/- (129) mice, we observed a compartmentalization of immunoreactive signal within the glomeruli: they were labeled uniformly with the Olfr1507 antibody, but visualized only partially with the GFP antibody. The segregation in glomeruli in MOR28-IRESgap-GFP +/-(B6) mice has been reported previously (Ishii et al., 2001) , and there is a single amino acid polymorphism between B6 (isoleucine) and 129 (valine) at residue 50. Interestingly, we also observed a compartmentalization of the two populations of OSNs in glomeruli of MOR28-IRES-gap-GFP +/- (129) mice. This 20 compartmentalization may reflect a subtle difference in RNA or protein expression level between the wild-type and 129 alleles, or an undocumented effect of the gap-GFP axonal marker. In this marker, the 20 N-terminal amino acid residues of GAP43 are fused to the N-terminus of the green fluorescent protein to target it to the plasma membrane (Moriyoshi et al., 1996) .
Probability of OR gene expression Probability of OR gene expression Probability of OR gene expression Probability of OR gene expression
We used MOR28-IRES-gap-GFP -/-mice (Serizawa et al., 2000) as validation that the Olfr1507 antibody is highly specific and sensitive for Olfr1507-expressing OSNs. We also determined that Olfr1507-expressing OSNs are distributed in an 'M'-like pattern in the MOE in a series of coronal sections. We have described a similar pattern of distribution of OSNs in the MOE for OSNs expressing mI7/Olfr2, M50/Olfr6, or SR1/Olfr124 (Bressel et al., 2016) . The number of Olfr1507-expressing OSNs in a 21-day old C57BL/6J mouse (43,500 ± 3,606) is slightly higher than the number of MOR256-17-expressing OSNs (37,023 ± 6,318) (Bressel et al., 2016 ).
When we assessed Olfr1507 expression in MOR28-IRES-gap-GFP +/-(B6) mice, we found that there was a preferential expression of the wild-type, B6-derived allele.
We observed a reduced preference of expression of the wild-type, 129-derived allele in MOR28-IRES-gap-GFP +/-(129) mice. When we compared the number of Olfr1507-expressing OSNs in wild-type mice, we found that there were more cells in B6 mice than in 129 mice, suggesting that the probability of Olfr1507 gene choice is higher when driven by the B6 promoter than the 129 promoter. There does appear to be an additional effect of the targeted mutations in terms of a slight reduction in the probability of gene choice.
Interestingly, Olfr1507 is the most proximal OR gene among a cluster of seven OR genes that are regulated by the H element (Tsuboi et al., 1999; Serizawa et al., 2000; 2003) . When the H element is deleted by gene targeting, the expression of Olfr1507 is abolished entirely, and the expression of the more distal OR genes is reduced in a distance-correlated fashion (Fuss et al., 2007; Nishizumi et al., 2007; Khan et al., 2011) . Moreover, the position of the Olfr1507 coding region in C57BL/6 mice is 11 kb closer to the H element compared to mice with a 129 background (Fuss 21 et al., 2007) . We speculate that the difference in distance of the H element to the Olfr1507 gene is causally related to the difference in probability of gene choice, measured operationally as the number of Olfr1507-expressing OSNs.
CONCLUSIONS CONCLUSIONS CONCLUSIONS CONCLUSIONS
Antibodies against mouse ORs are a valuable tool for understanding the biological distribution of OR proteins, and to characterize OR-specific glomeruli in the olfactory bulb when no gene-targeted strain is available. Their value to olfactory neuroscience may have been overshadowed by the success of the gene-targeted approach. The significance of reports based on custom-designed or home-made polyclonal antibodies is constrained by the lack of the commercial or public availability of these reagents, hampering replicability studies. Here we have characterized 40
commercially available antibodies against ORs. We have demonstrated that they have a reasonable probability of success for immunofluorescence in the MOE (20-30%), and can be highly specific and sensitive. The production of monoclonal antibodies against ORs will be an important next step. List of commercial antibodies raised against human and mouse ORs that yielded immunostaining in cryosections of the mouse MOE. As the peptide sequence of the antigens is not available, the region is given from which the antigenic peptide was designed. Antigen retrieval conditions, and optimal dilutions of the antibodies are indicated.
aa; amino acid, Citric acid AR; Antigen retrieval with citric acid buffer pH 6.0 in a pressure cooker, No AR; No antigen retrieval, Tris AR; Antigen retrieval with Tris buffer pH 9.0 in a pressure cooker.
27 Table 2  Table 2  Table 2  Table 2 (G) Olfr552 immunoreactivity was also detected in a glomerulus. Merge with DAPI.
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Scale bars, 20 µm. 
Highlights
• Odorant receptor proteins are expressed in mature olfactory sensory neurons of the mouse main olfactory epithelium.
• We screened 40 commercial antibodies against human and mouse ORs by immunofluorescence in the olfactory epithelium.
• Specificity and sensitivity of an antibody was evaluated for Olfr1507/MOR28
with a gene-targeted mouse strain.
• At least 20% of these antibodies are informative in immunohistochemical analyses of the mouse olfactory epithelium.
• The commercial availability of these antibodies should facilitate the replicability of results in the literature.
